S
Sam Milliken
Researcher at St. Vincent's Health System
Publications - 120
Citations - 3996
Sam Milliken is an academic researcher from St. Vincent's Health System. The author has contributed to research in topics: Transplantation & Internal medicine. The author has an hindex of 31, co-authored 106 publications receiving 3734 citations. Previous affiliations of Sam Milliken include The Royal Marsden NHS Foundation Trust & University of Basel.
Papers
More filters
Journal ArticleDOI
Fungal infections in cancer patients: an international autopsy survey.
Gerald P. Bodey,B Bueltmann,W Duguid,D. Gibbs,H Hanak,M Hotchi,G Mall,P. Martino,F Meunier,Sam Milliken +9 more
TL;DR: It is clearly demonstrates that fungal infections represent a common complication in cancer patients, especially in patients with leukemia.
Journal ArticleDOI
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
Orla Morrissey,Orla Morrissey,Sharon C.-A. Chen,Sharon C.-A. Chen,Sharon C.-A. Chen,Tania C. Sorrell,Tania C. Sorrell,Tania C. Sorrell,Sam Milliken,Peter G Bardy,Kenneth F. Bradstock,Jeff Szer,Catriona Halliday,Nicole Gilroy,John Moore,Anthony P. Schwarer,Stephen Guy,Ashish Bajel,Adrian R Tramontana,Tim Spelman,Tim Spelman,Monica A. Slavin +21 more
TL;DR: Use of aspergillus galactomannan and PCR to direct treatment reduced use of empirical antifungal treatment in high-risk haematology patients.
Journal ArticleDOI
Sun exposure may protect against non-Hodgkin lymphoma: a case-control study
Ann Maree Hughes,Bruce K. Armstrong,Claire M. Vajdic,Jennifer Turner,Andrew E. Grulich,Lin Fritschi,Sam Milliken,John M. Kaldor,Geza Benke,Anne Kricker +9 more
TL;DR: Increasing evidence that vitamin D may protect against cancer makes UV‐mediated synthesis of vitamin D a plausible mechanism whereby sun exposure might protect against NHL, and provides strong statistical evidence for an inverse association between sun exposure and NHL.
Journal ArticleDOI
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32
Lucia Conde,Eran Halperin,Nicholas K. Akers,Kevin M. Brown,Karin E. Smedby,Nathaniel Rothman,Alexandra Nieters,Susan L. Slager,Angela Brooks-Wilson,Luz Agana,Jacques Riby,Jianjun Liu,Hans-Olov Adami,Hatef Darabi,Henrik Hjalgrim,Hui Qi Low,Keith Humphreys,Mads Melbye,Ellen T. Chang,Bengt Glimelius,Wendy Cozen,Scott Davis,Patricia Hartge,Lindsay M. Morton,Maryjean Schenk,Sophia S. Wang,Bruce K. Armstrong,Anne Kricker,Sam Milliken,Mark P. Purdue,Claire M. Vajdic,Peter Boyle,Qing Lan,Shelia Hoar Zahm,Yawei Zhang,Tongzhang Zheng,Nikolaus Becker,Yolanda Benavente,Paolo Boffetta,Paul Brennan,Katja Butterbach,Pierluigi Cocco,Lenka Foretova,Marc Maynadié,Silvia de Sanjosé,Anthony Staines,John J. Spinelli,Sara J. Achenbach,Timothy G. Call,Nicola J. Camp,Martha Glenn,Neil E. Caporaso,James R. Cerhan,Julie M. Cunningham,Lynn R. Goldin,Curtis A. Hanson,Neil E. Kay,Mark C. Lanasa,Jose F. Leis,Gerald E. Marti,Kari G. Rabe,Laura Z. Rassenti,Logan G. Spector,Sara S. Strom,Celine M. Vachon,J. Brice Weinberg,Elizabeth A. Holly,Stephen J. Chanock,Martyn T. Smith,Paige M. Bracci,Christine F. Skibola +70 more
TL;DR: Two variants associated with follicular lymphoma at 6p21.32 are identified, supporting the idea that major histocompatibility complex genetic variation influences follicle lymphoma susceptibility.
Journal Article
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
John A. Snowden,Jakob Passweg,John Moore,Sam Milliken,Sam Milliken,Paul Cannell,Paul Cannell,Jacob M van Laar,R J Verburg,R J Verburg,Jeff Szer,Jeff Szer,Kerry Taylor,David Joske,Simon Rule,Simon Rule,Sarah J. Bingham,Paul Emery,Paul Emery,Richard K. Burt,Ray M. Lowenthal,Ray M. Lowenthal,Patrick Durez,Robert John McKendry,Robert John McKendry,Steven Z. Pavletic,Steven Z. Pavletic,Ildefonso Espigado,Esa Jantunen,Esa Jantunen,Ashwin Kashyap,Ashwin Kashyap,Marco Rabusin,Peter Brooks,Peter Brooks,Christopher Bredeson,Alan Tyndall +36 more
TL;DR: Autologous HSCT is a relatively safe form of salvage treatment in severe, resistant RA, and in these open label studies significant responses were achieved in most patients, with over 50% achieving an ACR 50 or more response at 12 months.